B G McCarthy
Overview
Explore the profile of B G McCarthy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Daniel D, Wozniak P, Mack R, McCarthy B
Psychopharmacol Bull
. 1998 May;
34(1):61-9.
PMID: 9564200
Sertindole is an atypical antipsychotic that is efficacious in schizophrenia and is associated infrequently with extrapyramidal symptoms (EPS). This study assessed time to treatment failure with 24 mg/day sertindole or...
2.
McCarthy B, Hsieh S, STOCKS A, Hauer P, Macko C, Cornblath D, et al.
Neurology
. 1995 Oct;
45(10):1848-55.
PMID: 7477980
Objective: To use punch skin biopsies to evaluate the loss of intra-epidermal nerve fibers in sensory neuropathies. Background: Previous assessments of epidermal nerve fibers have been constrained by relatively insensitive...
3.
Sack Jr G, Talbot Jr C, McCarthy B, Harris E, Kastner D, Gruberg L, et al.
Hum Genet
. 1991 Aug;
87(4):506-8.
PMID: 1679035
We studied the relationship between the autosomal recessive trait familial Mediterranean fever (FMF) and the serum amyloid A (SAA) genes by comparing alleles of a highly polymorphic dinucleotide repeat and...
4.
Peroutka S, McCarthy B, Guan X
Life Sci
. 1991 Jan;
49(6):409-18.
PMID: 1650872
The ability of nineteen tryptamine derivatives to interact with putative 5-hydroxytryptamine1D (5-HT1D) receptor binding sites in bovine caudate was analyzed. Sixteen of the nineteen agents competed, with variable potency, for...
5.
Glennon R, Ismaiel A, McCarthy B, Peroutka S
Eur J Pharmacol
. 1989 Sep;
168(3):387-92.
PMID: 2583244
The binding affinities of a series of arylpiperazine derivatives at [3H]quipazine-labeled central 5-HT3 sites were investigated. Features determined to be important for binding include the N4 piperazine nitrogen atom (but...
6.
McCarthy B, Peroutka S
Headache
. 1989 Jul;
29(7):420-2.
PMID: 2547733
The potency of dihydroergotamine (DHE) was determined at 13 neurotransmitter receptors using radioligand binding techniques. DHE is a potent agent (i.e. affinity value less than 100 nM) at 5-hydroxytryptamine1A (5-HT1A),...
7.
Peroutka S, McCarthy B
Eur J Pharmacol
. 1989 Apr;
163(1):133-6.
PMID: 2545459
The ability of sumatriptan (GR 43175; 3-[2-dimethylamino]ethyl-N-methyl-1H-indole-5 methane sulphonamide) to interact with 13 neurotransmitter receptor sites was determined using radioligand binding techniques. Sumatriptan displayed the highest affinity for 5-HT1D (Ki...
8.
Peroutka S, Sleight A, McCarthy B, Pierce P, Schmidt A, Hekmatpanah C
J Neuropsychiatry Clin Neurosci
. 1989 Jan;
1(3):253-62.
PMID: 2562495
The past decade has seen important advances in the clinical utility of serotonergic agents. The putative novel anxiolytic effects of 5-HT1A partial agonists such as buspirone, the antidepressant effects of...
9.
McCarthy B, Peroutka S
Aviat Space Environ Med
. 1988 Jan;
59(1):63-6.
PMID: 3355470
Radioligand binding studies were used to analyze muscarinic cholinergic receptor subtypes in human cortex and pons. Muscarinic cholinergic receptors were labeled by 3H-quinuclidinyl benzilate (3H-QNB). Scopolamine was equipotent in both...